For example, KNK437, a benzylidene lactam compound and a pan-HSP inhibitor exerts its anti-tumor activity by inhibiting the expression of HSPs such as HSP27, HSP40, HSP72, and HSP110 [108,109]. Here, DNAJB1 is linked to neoplasm.